Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JSKN033 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
NCT07797153Phase 3Not yet recruiting
- Sponsor
- Alphamab Oncology
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 3 trial of JSKN033 in Cervical Cancer (CC), sponsored by Alphamab Oncology. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
JSKN033
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07797153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07797153.